Tamarixetin targets were also associated with Pathways in cancer, Proteoglycans in cancer, PI3K-Akt signaling pathway, Estrogen signaling pathway, Prostate cancer and Rap1 signaling pathway. Here, AKT1 is linked to prostate carcinoma.